BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37603610)

  • 1. Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes.
    Kowalik MA; Taguchi K; Serra M; Caddeo A; Puliga E; Bacci M; Koshiba S; Inoue J; Hishinuma E; Morandi A; Giordano S; Perra A; Yamamoto M; Columbano A
    Hepatology; 2024 Apr; 79(4):829-843. PubMed ID: 37603610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
    Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
    J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism.
    Song MY; Lee DY; Chun KS; Kim EH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
    Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
    Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC.
    Mattu S; Zavattari P; Kowalik MA; Serra M; Sulas P; Pal R; Puliga E; Sutti S; Foglia B; Parola M; Albano E; Giordano S; Perra A; Columbano A
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):113-127. PubMed ID: 34530178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shinorine ameliorates chromium induced toxicity in zebrafish hepatocytes through the facultative activation of Nrf2-Keap1-ARE pathway.
    Shaw P; Sen A; Mondal P; Dey Bhowmik A; Rath J; Chattopadhyay A
    Aquat Toxicol; 2020 Nov; 228():105622. PubMed ID: 32947073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
    Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y
    Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2-Dependent Manner.
    Sano A; Kakazu E; Hamada S; Inoue J; Ninomiya M; Iwata T; Tsuruoka M; Sato K; Masamune A
    Hepatology; 2021 Sep; 74(3):1271-1286. PubMed ID: 33724516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism.
    Chartoumpekis DV; Wakabayashi N; Kensler TW
    Biochem Soc Trans; 2015 Aug; 43(4):639-44. PubMed ID: 26551705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver.
    Hu M; Zou Y; Nambiar SM; Lee J; Yang Y; Dai G
    Cell Cycle; 2014; 13(15):2349-58. PubMed ID: 25483186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway.
    Deng R; Zhu Y; Liu K; Zhang Q; Hu S; Wang M; Zhang Y
    Bioorg Chem; 2024 Apr; 145():107212. PubMed ID: 38377819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic and coordinated regulation of KEAP1-NRF2-ARE and p53/p21 signaling pathways is associated with acetaminophen injury responsive liver regeneration.
    Fan X; Chen P; Tan H; Zeng H; Jiang Y; Wang Y; Wang Y; Hou X; Bi H; Huang M
    Drug Metab Dispos; 2014 Sep; 42(9):1532-9. PubMed ID: 25002747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
    Panieri E; Saso L
    Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
    [No Abstract]   [Full Text] [Related]  

  • 16. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
    Tocmo R; Parkin K
    Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scutellarin attenuates hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and oxidative stress through regulating Keap1/Nrf2/ARE signaling.
    Wu H; Jia L
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31654068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment.
    Best SA; De Souza DP; Kersbergen A; Policheni AN; Dayalan S; Tull D; Rathi V; Gray DH; Ritchie ME; McConville MJ; Sutherland KD
    Cell Metab; 2018 Apr; 27(4):935-943.e4. PubMed ID: 29526543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.
    Hawkins KE; Joy S; Delhove JM; Kotiadis VN; Fernandez E; Fitzpatrick LM; Whiteford JR; King PJ; Bolanos JP; Duchen MR; Waddington SN; McKay TR
    Cell Rep; 2016 Mar; 14(8):1883-91. PubMed ID: 26904936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.